Transcriptional and physiological responses to chronic ACTH treatment by the mouse kidney.
Transcriptional and physiological responses to chronic ACTH treatment by the mouse kidney.
复制标题
DOI:
10.1152/physiolgenomics.00088.2009
复制
发表时间:
2010-02-04
影响因子:
4.6
通讯作者:
Bailey MA
中科院分区:
文献类型:
--
作者:
Dunbar DR;Khaled H;Evans LC;Al-Dujaili EA;Mullins LJ;Mullins JJ;Kenyon CJ;Bailey MA
We investigated the effects on urinary steroid and electrolyte excretion and renal gene expression of chronic infusions of ACTH in the mouse. ACTH caused a sustained increase in corticosteroid excretion; aldosterone excretion was only transiently elevated. There was an increase in the excretion of deoxycorticosterone, a weak mineralocorticoid, to levels of physiological significance. Nevertheless, we observed neither antinatriuresis nor kaliuresis in ACTH-treated mice, and plasma renin activity was not suppressed. We identified no changes in expression of mineralocorticoid target genes. Water turnover was increased in chronic ACTH-treated mice, as were hematocrit and hypertonicity: volume contraction is consistent with high levels of glucocorticoid. ACTH-treated mice exhibited other signs of glucocorticoid excess, such as enhanced weight gain and involution of the thymus. We identified novel ACTH-induced changes in 1) genes involved in vitamin D (Cyp27b1, Cyp24a1, Gc) and calcium (Sgk, Calb1, Trpv5) metabolism associated with calciuria and phosphaturia; 2) genes that would be predicted to desensitize the kidney to glucocorticoid action (Nr3c1, Hsd11b1, Fkbp5); and 3) genes encoding transporters of enzyme systems associated with xenobiotic metabolism and oxidative stress. Although there is evidence that ACTH-induced hypertension is a function of physiological cross talk between glucocorticoids and mineralocorticoids, the present study suggests that the major changes in electrolyte and fluid homeostasis and renal function are attributable to glucocorticoids. The calcium and organic anion metabolism pathways that are affected by ACTH may explain some of the known adverse effects associated with glucocorticoid excess.
登录
查看更多内容
影响因子:
12.3
作者:
Gentleman RC;Carey VJ;Bates DM;Bolstad B;Dettling M;Dudoit S;Ellis B;Gautier L;Ge Y;Gentry J;Hornik K;Hothorn T;Huber W;Iacus S;Irizarry R;Leisch F;Li C;Maechler M;Rossini AJ;Sawitzki G;Smith C;Smyth G;Tierney L;Yang JY;Zhang J
通讯作者:
Zhang J
影响因子:
19.6
作者:
Bailey, M. A.;Cantone, A.;Malnic, G.
通讯作者:
Malnic, G.
DOI:
10.1016/j.bbalip.2006.01.004
发表时间:
2006-02-01
影响因子:
4.8
作者:
Masuda, S;Strugnell, SA;Jones, G
通讯作者:
Jones, G
DOI:
10.1530/acta.0.1220599
发表时间:
1990-05-01
期刊:
ACTA ENDOCRINOLOGICA
影响因子:
--
作者:
KENYON, CJ;BROWN, WB;DAVIES, DL
通讯作者:
DAVIES, DL
影响因子:
13.6
作者:
Gaeggeler, HP;Gonzalez-Rodriguez, E;Rossier, BC
通讯作者:
Rossier, BC